Tenofovir-associated nephrotoxicity among a US national historical cohort of HIV-infected veterans risk modification by concomitant antiretrovirals
Journal of Acquired Immune Deficiency Syndromes Feb 16, 2018
LaFleur J, et al. - Researchers performed a comparison of renal adverse outcomes among treatment-naive HIV-infected patients initiating Tenofovir disoproxil fumarate (TDF)-containing regimens including efavirenz (EFV) or other agents. Findings revealed a significantly lower risk of chronic kidney disease in association with EFV + TDF/emtricitabine (FTC) vs other TDF-containing regimens in the Veterans Health Administration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
